SCHEMBL5458615

SCHEMBL5458615

CCCCC1CCN(C(CCC=O)c2oc3ccccc3c2C)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.35
CHRM2 P08172 3/20 0.35
CHRM4 P08173 3/20 0.35
CHRM5 P08912 3/20 0.35
CHRM3 P20309 3/20 0.35
DRD2 P14416 3/20 0.35
DRD4 P21917 2/20 0.35
ADRA1D P25100 2/20 0.35
ADRA1A P35348 2/20 0.35
ADRA1B P35368 2/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
HRH1 P35367 1/20 0.35
OPRK1 P41145 1/20 0.34
DPP4 P27487 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
LMNA P02545 1/20 0.32
DRD3 P35462 2/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009742 0.83 CHRM1 (0.39) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL5345346 0.70 CHRM5 (0.35) CHRM1CHRM5CHRM3DRD2HTR1A
SCHEMBL5336943 0.68 HRH3 (0.51) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL7010834 0.67 DPP4 (0.34) CHRM4CHRM5CHRM3ADRA1BDPP4
SCHEMBL5345293 0.66 CHRM1 (0.62) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL7014940 0.65 CHRM1 (0.39) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL13597015 0.62 DPP4 (0.63) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL4485151 0.61 DPP4 (0.36) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL13596973 0.60 DPP4 (0.67) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL13001877 0.59 NQO1 (0.41) NPC1PTPN1EYA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070155795-A1 MUSCARINIC AGONISTS ACADIA PHARMACEUTICALS INC. (US) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155795-A1 MUSCARINIC AGONISTS CHRM2, CHRM1, CHRM4 CHRM1 2/4885CHRM2 1/4885CHRM4 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.